Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambirix vaccine response in immunosuppressed children
NL-OMON38280Phase 4Active, not recruiting
- Sponsor
- Public Health Service of Amsterdam
- Start
- Aug 2009
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of hepatitis a vaccine + hepatitis b vaccine in hepatitis A (HAV) and hepatitis B (HBV) (2 arms), sponsored by Public Health Service of Amsterdam. Primary endpoints: Hepatitis A seroconversion rate, Hepatitis B seroconversion rate and 1 more. Started Aug 2009; status: active, not recruiting.
02
Drugs
hepatitis a vaccine + hepatitis b vaccine
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on NL-OMON38280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38280.